Indicators

Latest News about NVS

Recent news which mentions NVS

...

21 22 23 24 25 26 27 28 Next >

This Biotech Company Looks To Be Targeting A New Drug To Treat NASH, The Leading Cause of Liver Transplants

March 24, 2022

FDA Approves Novartis' Pluvicto As First Targeted Radioligand Therapy For Prostate Cancer

March 24, 2022

The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL

March 24, 2022

This Company Is Making Progress In Its Fight Against Rare, Terminal Cancers

March 22, 2022

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout

March 22, 2022

Morning Brief: Top Stories Dominating Financial Media on Tuesday, March 22

March 22, 2022

Novartis Suspends Some Investment, Business Activities In Russia

March 22, 2022

This group of stocks is flagging a rebound, and that’s good news for the S&P 500, says technical analyst

March 22, 2022

Pfizer and Novartis Are Betting On This Under-the-Radar Biotech. Should You?

March 19, 2022

2 Top Stocks to Buy in March and Hold Forever

March 15, 2022

Novartis's Data Reinforces Age-Appropriate Development With Zolgensma Gene Therapy Study

March 14, 2022

Biogen Posts New Updates Across its Spinraza SMA Research Program

March 14, 2022

Why Another ADHD Stimulant? Cingulate Inc. Believes It's All About The Timing

March 14, 2022

3 No-Brainer Stocks to Buy With $1,000 Right Now

March 14, 2022

Hutchmed Roils Markets With Changing of Its Guard, U.S. Delisting Threat

March 11, 2022

NEJM Publication Shows Novartis' Kisqali With Longest Median Overall Survival In Breast Cancer Setting

March 10, 2022

7 Drug Stocks To Consider After the Viatris Plunge

March 10, 2022

The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout

March 08, 2022

Voyager Therapeutics Shares Jump On Novartis Option Agreement For Gene Therapy Programs

March 08, 2022

Pharmaceutical Companies Are Reportedly Refocusing On Mysterious Rise In Shingles Infections As COVID Declines

March 07, 2022

Viatris Just Snagged a Major FDA Approval

March 03, 2022

Consumer Spending, E-Commerce, and the Business of Lodging

March 02, 2022

36 Stocks To Watch After Biden's First State of The Union Address

March 02, 2022

This Biotech Company Reports Making Ground-Breaking Strides In Combating Solid Tumors

February 23, 2022

The Daily Biotech Pulse: Regeneron-Sanofi Halt Late-Stage Dupixent Study, Agios Gets FDA Nod, Safety Scare For GSK's RSV Vaccine, Shockwave Jumps On Earnings

February 18, 2022

Sanofi-Regeneron's Dupixent Falls Short In Chronic Spontaneous Urticaria Trial

February 18, 2022

New FDA program could boost drug development for rare diseases

February 15, 2022

3 High-Yield Dividend Stocks to Buy and Hold for Decades

February 12, 2022

Alnylam Clocks 76% Increase In Q4 Product Sales, Expects FY22 Product Sales Of Up To $1B

February 10, 2022

The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly

February 10, 2022

...

21 22 23 24 25 26 27 28 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.